Cognitive Neuroscience-Based Approaches to Measuring and Improving Treatment Effects on Cognition in Schizophrenia: The CNTRICS Initiative
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The goal of this article is to discuss ways to further improve the search for potentially procognitive agents that could be used to enhance cognition and functional outcome in schizophrenia. In particular, we focus on the potential advantages to this process of using a contemporary, cognitive neuroscience-based approach to measuring cognitive function in clinical trials of procognitive agents in schizophrenia. These tools include computer-administered tasks that measure specific cognitive systems (such as attention, working memory, long-term memory, cognitive control) as well as the component cognitive processes that comprise these more overarching systems. The advantages of using these tools include the ability to identify and use homologous animal and human models in the drug discovery and testing process and the ability to incorporate noninvasive functional imaging measures into clinical trial contexts at several different phases of the drug development process. However, despite the clear potential advantages to using such methods, a number of barriers exist to their translation from basic science tools to tools for drug discovery. We discuss the development and implementation of a new project, Cognitive Neuroscience Treatment to Improve Cognition in Schizophrenia, designed to identify and overcome these barriers to the translation of cognitive neuroscience measures and methods into regular use in the drug discovery and development process of cognition-enhancing agents for use in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The episodic buffer: a new component of working memory?
Baddeley, A. (2000) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(00)01538-2 · Cited by 7,359
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Models of Working Memory: Mechanisms of Active Maintenance and Executive Control
Miyake, A., & Shah, P. (1999) · Cited by 2,451
The role of acetylcholine in learning and memory
Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592
Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422 · cited 3×
“These criteria were then used, in a second on-line survey, to develop an initial list of candidate constructs from 6 broad cognitive domains: (1) working memory, (2) episodic memory, (3) attention, (4) executive function, (5) perception, and (6) social cognitive and affective processing.”
BackgroundMethodWorking Memory: The Multiple-Component Model
Baddeley, A. D., & Logie, R. H. (1999) · Models of Working Memory · doi:10.1017/cbo9781139174909.005 · Cited by 1,374
Neuropsychological Function in Schizophrenia: Selective Impairment in Memory and Learning
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,155
Schizophrenics Show Spatial Working Memory Deficits
Park, S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120063009 · Cited by 945
Cited by
Fett, A.-K. J., Viechtbauer, W., Dominguez, M.-D.-G., Penn, D. L., van Os, J., & Krabbendam, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.07.001 · Cited by 1,833
Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292
Self-citationNeurocognition in first-episode schizophrenia: a meta-analytic review.
Mesholam-Gately, R. I., Giuliano, A. J., Goff, K. P., Faraone, S. V., & Seidman, L. J. (2009) · Neuropsychology · doi:10.1037/a0014708 · Cited by 1,130
The Neural Bases of Distraction and Reappraisal
McRae, K., Hughes, B., Chopra, S., Gabrieli, J. D. E., Gross, J. J., & Ochsner, K. N. (2010) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21243 · Cited by 642
Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior
Morris, S. E., & Cuthbert, B. N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.1/smorris · Cited by 638
“CNTRICS was focused on translating the knowledge and methods of cognitive, social, and affective neuroscience into a set of cognitive systems and processes to be targeted for treatment and measurement using standardized, psychometrically sound measures in behavioral as well as neuroimaging studies.(5) Although both MA…”
The global cognitive impairment in schizophrenia: consistent over decades and around the world
Schaefer, J., Giangrande, E., Weinberger, D. R., & Dickinson, D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.009 · Cited by 605
“Newer investigative methods from the cognitive and affective neuroscience literature will test whether this broad impairment can be divided into separable component processes (Carter and Barch, 2007).”
BackgroundMiyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning
Lesh, T. A., Niendam, T. A., Minzenberg, M. J., & Carter, C. S. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.156 · Cited by 506
Self-citationCognitive Impairment in Schizophrenia
Keefe, R. S. E., & Harvey, P. D. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_2 · Cited by 472
Linking neurodevelopmental and synaptic theories of mental illness through DISC1
Brandon, N. J., & Sawa, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3120 · Cited by 428
Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders
Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.024 · Cited by 395
Cognition and resting-state functional connectivity in schizophrenia
Sheffield, J. M., & Barch, D. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.007 · Cited by 362
Self-citationEack, S. M., Hogarty, G. E., Cho, R. Y., Prasad, K. M. R., Greenwald, D. P., Hogarty, S. S., & Keshavan, M. S. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.63 · Cited by 360
Toward New Approaches to Psychotic Disorders: The NIMH Research Domain Criteria Project
Cuthbert, B. N., & Insel, T. R. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq108 · Cited by 357
Millan, M. J., Fone, K., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 347
Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder
Lewandowski, K. E., Cohen, B. M., & Öngur, D. (2011) · Psychological Medicine · doi:10.1017/s0033291710001042 · Cited by 336
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
“As a result, current efforts are based primarily on our understanding of the theoretical constructs and neurobiology related to cognition (Carter and Barch, 2007; Chudasama and Robbins, 2006).”
Worth a glance: Using eye movements to investigate the cognitive neuroscience of memory.
Hannula, D. E. (2010) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00166 · Cited by 326
Ochsner, K. N. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.024 · Cited by 298
Subramaniam, K., Luks, T. L., Fisher, M., Simpson, G. V., Nagarajan, S., & Vinogradov, S. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.024 · Cited by 289
Cognition in schizophrenia: Past, present, and future
Green, M. F., & Harvey, P. D. (2014) · Schizophrenia Research: Cognition · doi:10.1016/j.scog.2014.02.001 · Cited by 258
Social Cognition in Schizophrenia
Green, M. F., & Leitman, D. I. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn045 · Cited by 214
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Neural Systems Supporting the Control of Affective and Cognitive Conflicts
Ochsner, K. N., Hughes, B., Robertson, E. R., Cooper, J. C., & Gabrieli, J. D. E. (2009) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21129 · Cited by 185
Social Cognition in Schizophrenia
Green, M. F., & Horan, W. P. (2010) · Current Directions in Psychological Science · doi:10.1177/0963721410377600 · Cited by 145
nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms
Sarter, M., Parikh, V., & Howe, W. M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.019 · Cited by 123
Transcranial magnetic stimulation: A neuroscientific probe of cortical function in schizophrenia
McClintock, S. M., Freitas, C., Oberman, L., Lisanby, S. H., & Pascual-Leone, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.031 · Cited by 101
BDNF as a Biomarker of Cognition in Schizophrenia/Psychosis: An Updated Review
Nieto, R. R., Carrasco, A., Corral, S., Castillo, R., Gaspar, P. A., Bustamante, M. L., & Silva, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.662407 · Cited by 83
Leveraging the cortical cholinergic system to enhance attention
Demeter, E., & Sarter, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.060 · Cited by 75
Sarapas, C., Shankman, S. A., Harrow, M., & Goldberg, J. F. (2012) · Journal of Abnormal Psychology · doi:10.1037/a0028141 · Cited by 43
Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery
McArthur, R. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.02.004 · Cited by 42
Visual context processing in bipolar disorder: a comparison with schizophrenia
Yang, E., Tadin, D., Glasser, D. M., Wook Hong, S., Blake, R., & Park, S. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00569 · Cited by 38
Eack, S. M., Newhill, C. E., & Keshavan, M. S. (2016) · Journal of the Society for Social Work and Research · doi:10.1086/686538 · Cited by 37
“The importance of treating cognitive impairments in those with schizophrenia has led to several initiatives to support the development of cognitive enhancing interventions (Marder & Fenton, 2004; Carter & Barch, 2007).”
BackgroundAcheson, D. T., Twamley, E. W., & Young, J. W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00103 · Cited by 26
Koychev, I., Barkus, E., Ettinger, U., Killcross, S., Roiser, J. P., Wilkinson, L., & Deakin, B. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414450 · Cited by 24
“Another relevant project is the CNTRICS (Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia) initiative (Carter and Barch, 2007) which aims to identify promisingmeasures of perception and integration for validation as biomarkers for pathogenesis and drug development.”
BackgroundA dimensional approach to functional movement disorders: Heresy or opportunity
Spagnolo, P. A., Garvey, M., & Hallett, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.04.005 · Cited by 23
Turner, K. M., & Burne, T. H. J. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00097 · Cited by 16
“From these domains various clinical tests were selected by the follow-up group, Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS), to be used in validating drug efficacy and to improve consistency between research groups (Carter and Barch, 2007).”
MethodBhakta, S. G., Cavanagh, J. F., Talledo, J. A., Kotz, J. E., Benster, L., Roberts, B. Z., Nungaray, J. A., Brigman, J. L., Light, G. A., Swerdlow, N. R., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01257-2 · Cited by 13
“To this end, several initiatives have sought to develop cross-species tests with tightly defined behaviors and neurobiological underpinnings [2, 3], to identify biomarkers that can be translated across species and predict treatment sensitivity.”
Background
Metadata
- Authors
- Carter, C. S., & Barch, D. M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-17
- Volume
- 33
- Issue
- 5
- Pages
- 1131-1137
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2100927195
- Cited by
- 274
- References
- 41
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.